TYPE

Aware Ranks Top Performer in NIST Face Analysis Technology Evaluation (FATE) Benchmarking Test While Optimizing Demographic Parity

Retrieved on: 
Wednesday, October 11, 2023
Pais, IP, Algorithm, Deep learning, AWRE, FATE, FRVT, AI, Facial recognition, NIST, PAD, Data, National Institute of Standards and Technology, 2D, ISO, Benchmarking, Consistency, PAI, Software, TYPE, Medical device

The independent NIST results show Aware as a leader in presentation attack detection liveness technology while affirming Aware’s leadership position in optimizing demographic parity.

Key Points: 
  • The independent NIST results show Aware as a leader in presentation attack detection liveness technology while affirming Aware’s leadership position in optimizing demographic parity.
  • Eliminating racial, gender, and other biases to achieve optimal demographic parity has been Aware’s focus for years in both face recognition and presentation attack detection.
  • “Aware applauds NIST for both the rigor and the thought leadership demonstrated in designing this evaluation,” says Dr. Mohamed Lazzouni, Chief Technology Officer at Aware.
  • For more information regarding the NIST FATE report and results, or to learn more about Aware’s presentation attack detection systems, contact Aware today.

ELAHERE® Shows Overall and Progression-Free Survival Benefit Regardless of Prior PARPi Exposure or Prior Lines of Therapy in FRα-Positive Platinum-Resistant Ovarian Cancer

Retrieved on: 
Thursday, September 28, 2023
Oncology, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, Topotecan, European Society of Gynaecological Oncology, Pros, Bevacizumab, University, Progression-free survival, Neoplasm, Catholic University of Leuven (1834–1968), OS, IC, Cancer, Paclitaxel, PLD, ESGO, PFS, University Clinical Centre in Gdańsk, Mirvetuximab soravtansine, IMGN, PROC, ASCO, Congress, Ventana, American Society of Clinical Oncology, Patient, Physician, TYPE, Annual general meeting, CRS, Spacecraft, GOG, PARP, Society, ORR, Safety, Pharmaceutical industry, Medical imaging

Patients were stratified by number of prior lines of therapy (14% had one prior line of therapy, 40% had two prior lines of therapy, and 46% had three prior lines of therapy) and by IC chemotherapy, with paclitaxel as the most commonly chosen (41%), followed by PLD (36%) and topotecan (23%).

Key Points: 
  • Patients were stratified by number of prior lines of therapy (14% had one prior line of therapy, 40% had two prior lines of therapy, and 46% had three prior lines of therapy) and by IC chemotherapy, with paclitaxel as the most commonly chosen (41%), followed by PLD (36%) and topotecan (23%).
  • 62% of patients received prior bevacizumab; 55% received a prior PARP inhibitor.
  • Key secondary endpoints include objective response rate (ORR), overall survival (OS), and patient-reported outcomes (PROs).
  • ELAHERE demonstrated clinically meaningful improvements in PFS and ORR by investigator assessment and in OS compared to IC chemotherapy, regardless of prior lines of therapy (PLOT).

Revolutionizing Web3: TypeIt's Innovative Web3 Keyboard Changes the Game

Retrieved on: 
Monday, August 14, 2023
WORD, DID, DAO, NFT, Smartphone, Cryptocurrency, Multimedia, Binance, Non-fungible token, Blackbox, TYPE, BSC, Growth, Blockchain, Ecosystem, Video game, Web3, Android, Bitget

Seamlessly downloadable and user-friendly on Android devices, TypeIt boasts an accessible entry point compared to many existing Web3 apps.

Key Points: 
  • Seamlessly downloadable and user-friendly on Android devices, TypeIt boasts an accessible entry point compared to many existing Web3 apps.
  • The BSC Chain and Binance NFT market have witnessed the swift ascension of TypeIt's Web3 keyboards to coveted commodities.
  • In a pioneering move, TypeIt's revolutionary keyboard redefines the essence of Web3 interaction, empowering users with every tap of their keys.
  • Experience the future of typing with TypeIt and unlock a world where your actions are rewarded in the crypto realm.

Quantum-South identifies alternatives to boost Amerijet International's Cargo Load Factor by up to 30% with cutting-edge solution

Retrieved on: 
Tuesday, July 25, 2023
Aircraft, PQA, AKES, POC, Miami International Airport, Airport, Wilson, CoG, Landing slot, TYPE, Transport, B757, Airline, Rail freight transport, Concept, Amerijet International

The project concentrated on leveraging aircraft loading optimization to enhance cargo load factor and revenue per flight.

Key Points: 
  • The project concentrated on leveraging aircraft loading optimization to enhance cargo load factor and revenue per flight.
  • Quantum-South's solution was seamlessly integrated with Amerijet's cargo management system, powered by the SmartKargo backend application, further enhancing the efficiency and effectiveness of cargo operations.
  • The innovative solution identified loading alternatives that increased payload by up to 30% and volume by up to 76%.
  • The company also plans to explore automated planning of areas such as oversize cargo, consolidated cargo, bulk cargo space, and B757 configurations.

TypeIt (TYPE) Set to Launch on Bitget Launchpad

Retrieved on: 
Monday, July 3, 2023
AM, Participation, BGB, Non-fungible token, Bitget, TYPE, Cryptocurrency, Launch pad

Victoria, Seychelles--(Newsfile Corp. - July 3, 2023) - TypeIt (TYPE) is a revolutionary new keyboard that allows users to earn tokens simply by using it to conduct their day-to-day typing activities. This innovative keyboard has converted keyboard themes into non-fungible tokens, or NFTs, which users can own and use to earn tokens as they type.

Key Points: 
  • TypeIt (TYPE) is coming soon to Bitget Launchpad.
  • Participants' BGB investment cap is based on user average BGB holdings during the calculation period.
  • After the commitment period ends, the system will calculate the amount of Launchpad tokens to be allocated to each user.
  • After the allocation to each user is determined, Bitget will deduct the BGB from the user account accordingly.

SMX ISSUES SHAREHOLDER ADVISORY TO PROVIDE GUIDANCE AND BEST PRACTICES TO PREVENT STOCK LOANS TO SHORT SELLERS

Retrieved on: 
Wednesday, April 5, 2023
Communication, CASH, SMX, Senior, ANY, TYPE, Security (finance)

SMX management believes that all holders of its ordinary shares should hold their SMX shares in a TYPE 1 CASH ACCOUNT.

Key Points: 
  • SMX management believes that all holders of its ordinary shares should hold their SMX shares in a TYPE 1 CASH ACCOUNT.
  • This creates an opening for short sellers to borrow SMX shares to short the Company, which could be resulting in downward pressure on SMX shares.
  • Even though an SMX shareholder may not own SMX shares on margin, the brokerage firm can legally lend any position in a shareholder's Type 2 Margin Account.
  • With the help of its valued shareholders, SMX is striving to be best positioned to deliver long-term shareholder value.

Pharmascience Canada launched (PR)pms-DEFERASIROX (TYPE J), a generic drug indicated in the management of chronic iron

Retrieved on: 
Wednesday, January 18, 2023
Anemia, TYPE, Ageing, Thalassemia, Tablet, Safety, Patient, Deferoxamine, Dietary supplement

MONTRÉAL, Jan. 18, 2023 /CNW Telbec/ - Pharmascience Canada now adds PRpms-DEFERASIROX (TYPE J) to its product catalogue, available in 90 mg and 360 mg tablets.

Key Points: 
  • MONTRÉAL, Jan. 18, 2023 /CNW Telbec/ - Pharmascience Canada now adds PRpms-DEFERASIROX (TYPE J) to its product catalogue, available in 90 mg and 360 mg tablets.
  • The 180 mg tablets will be available in a few weeks only.
  • pms-DEFERASIROX (TYPE J) is used to treat chronic iron overload in:
    adult patients and children aged 6 years and older who receive blood transfusions for the treatment of anemias;
    children aged 2 to 5 years who receive blood transfusions for the treatment of anemias, and who cannot be adequately treated with deferoxamine;
    adult patients and children aged 10 years and older with thalassemia syndromes who do not require regular blood transfusions for the treatment of anemia.
  • With the same safety and efficacy profile as the brand-name product, Jadenu®, PRpms-DEFERASIROX (TYPE J) is available at a lower cost.

Super Trainer Megan Davies Redefines Training Mentality; Highlights Importance of Feeling Good with Launch of “Sure Thing”

Retrieved on: 
Wednesday, December 21, 2022
Fitness & Nutrition, Health, Boredom, Sure thing, Attitude, Multimedia, Eating, NYSE, Super, The Beachbody Company, Diet, Health, Urban Saints, Life, TYPE, Fashion, Milk

Building upon the tremendous success of her past programs, Megan invites participants to achieve the lifestyle they deserve through her unique approach to fitness – TYPE TRAINING™.

Key Points: 
  • Building upon the tremendous success of her past programs, Megan invites participants to achieve the lifestyle they deserve through her unique approach to fitness – TYPE TRAINING™.
  • View the full release here: https://www.businesswire.com/news/home/20221221005139/en/
    TYPE TRAINING™ alternates weekly between endurance and power-based strength training to train both fast-twitch muscle (power) and slow-twitch muscle (endurance).
  • It is expertly designed to leave you feeling challenged, but never strained or overworked.
  • “With Sure Thing, the goal is to help people feel good about themselves and be proud of every moment.

2D Fighting Game "MELTY BLOOD: TYPE LUMINA" Announcing New Free Playable Characters "Ushiwakamaru" and "The Count of Monte Cristo" and the new addition of Spanish, French, and Brazilian Portuguese languages

Retrieved on: 
Sunday, December 11, 2022
Tradition, The Count of Monte Cristo, TYPE, UTC, Smartphone, Fate/Grand Order, LUMINA, Multimedia, Casino, Film, Satellite navigation device

New playable characters "Ushiwakamaru" and "The Count of Monte Cristo" available in a free update on December 15.

Key Points: 
  • New playable characters "Ushiwakamaru" and "The Count of Monte Cristo" available in a free update on December 15.
  • "Ushiwakamaru" and "The Count of Monte Cristo" are characters who appeared in the smartphone game "Fate/Grand Order".
  • "MELTY BLOOD: TYPE LUMINA" will be available in Spanish, French, and Brazilian Portuguese from December 15 at 5:00(UTC), 2022*1,2.
  • Currently "MELTY BLOOD: TYPE LUMINA" is available in five languages, Japanese, English, Chinese (Traditional and Simplified), and Korean.

2D Fighting Game "MELTY BLOOD: TYPE LUMINA" Announcing New Free Playable Characters "Ushiwakamaru" and "The Count of Monte Cristo" and the new addition of Spanish, French, and Brazilian Portuguese languages

Retrieved on: 
Sunday, December 11, 2022
Tradition, The Count of Monte Cristo, TYPE, UTC, Smartphone, Fate/Grand Order, LUMINA, Casino, Film, Satellite navigation device

New playable characters "Ushiwakamaru" and "The Count of Monte Cristo" available in a free update on December 15.

Key Points: 
  • New playable characters "Ushiwakamaru" and "The Count of Monte Cristo" available in a free update on December 15.
  • "Ushiwakamaru" and "The Count of Monte Cristo" are characters who appeared in the smartphone game "Fate/Grand Order".
  • "MELTY BLOOD: TYPE LUMINA" will be available in Spanish, French, and Brazilian Portuguese from December 15 at 5:00(UTC), 2022*1,2.
  • Currently "MELTY BLOOD: TYPE LUMINA" is available in five languages, Japanese, English, Chinese (Traditional and Simplified), and Korean.